- Home
- VANI vs NOM Comparison
VANI vs NOM Comparison
Compare VANI & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- NOM
- Stock Information
- Founded
- VANI 1998
- NOM 1993
- Country
- VANI United States
- NOM United States
- Employees
- VANI N/A
- NOM N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NOM Investment Managers
- Sector
- VANI Health Care
- NOM Finance
- Exchange
- VANI Nasdaq
- NOM Nasdaq
- Market Cap
- VANI 68.1M
- NOM N/A
- IPO Year
- VANI 2014
- NOM N/A
- Fundamental
- Price
- VANI $1.26
- NOM $10.68
- Analyst Decision
- VANI Strong Buy
- NOM
- Analyst Count
- VANI 1
- NOM 0
- Target Price
- VANI $4.00
- NOM N/A
- AVG Volume (30 Days)
- VANI 66.4K
- NOM 6.9K
- Earning Date
- VANI 05-13-2025
- NOM 01-01-0001
- Dividend Yield
- VANI N/A
- NOM 3.39%
- EPS Growth
- VANI N/A
- NOM N/A
- EPS
- VANI N/A
- NOM N/A
- Revenue
- VANI N/A
- NOM N/A
- Revenue This Year
- VANI N/A
- NOM N/A
- Revenue Next Year
- VANI N/A
- NOM N/A
- P/E Ratio
- VANI N/A
- NOM N/A
- Revenue Growth
- VANI N/A
- NOM N/A
- 52 Week Low
- VANI $0.91
- NOM $8.52
- 52 Week High
- VANI $2.09
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- VANI 77.37
- NOM 53.61
- Support Level
- VANI $1.13
- NOM $10.34
- Resistance Level
- VANI $1.16
- NOM $10.79
- Average True Range (ATR)
- VANI 0.05
- NOM 0.21
- MACD
- VANI 0.02
- NOM -0.02
- Stochastic Oscillator
- VANI 92.86
- NOM 61.51
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.